A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old
PHASE3CompletedINTERVENTIONAL
Enrollment
122
Participants
Timeline
Start Date
November 1, 2012
Primary Completion Date
January 28, 2013
Study Completion Date
March 31, 2013
Conditions
Influenza
Interventions
BIOLOGICAL
AdimFlu-V
Trial Locations (1)
Unknown
Chang Gung Memorial Hospital at Linkuo, Taoyuan District
NCT01755364 - A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old | Biotech Hunter | Biotech Hunter